College of American Pathologists: Updated Breast Cancer Guideline Refines Testing to Better Identify Patients Likely to Benefit From Treatment
January 14, 2020
January 14, 2020
NORTHFIELD, Illinois, Jan. 14 -- The College of American Pathologists issued the following news release:
* * *
- Accurate endocrine receptor testing is critical to optimal treatment plans
* * *
The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly by the College of American Pathologists (CAP) and the American Society of Clinical Oncology (ASCO), reaffirms much of the original guidance . . .
* * *
- Accurate endocrine receptor testing is critical to optimal treatment plans
* * *
The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly by the College of American Pathologists (CAP) and the American Society of Clinical Oncology (ASCO), reaffirms much of the original guidance . . .